Nath Bio-Genes (India) Limited (NATHBIOGEN) — regulation 31
Nath Bio-Genes (India) Limited filed its SEBI Regulation 31 disclosure for the year ended March 31, 2026, detailing promoter and public shareholding patterns. The filing includes updates on promoter group entities and their shareholding statuses as of April 7, 2026, submitted to BSE and NSE for compliance records.
About Nath Bio-Genes (India) Limited (NATHBIOGEN)
Fast Moving Consumer Goods · Agricultural Food & other Products · Listed on NSE
📡 Get AI alerts when NATHBIOGEN files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track NATHBIOGEN — Free💡 Ask AI about this filing
📊 More NATHBIOGEN filings
- Financial Results — 26 June 2026 Nath Bio-Genes (India) Limited announced that its trading window will close on 1 July 2026 and remai...
- 🔴 Financial Results — 11 May 2026 Nath Bio-Genes reported FY26 revenue of **₹4,316 million**, up 19% YoY, with PAT at **₹384 million**...
- 🟡 Board Meeting — 4 May 2026 Nath Bio-Genes (India) Limited announced the outcome of its Board meeting on 4 May 2026, approving s...
- 🔴 Financial Results — 4 May 2026 Nath Bio-Genes reported FY26 revenue of **₹4,316 crores**, up 19% YoY, driven by cotton (+28% value ...
- 🔴 Financial Results — 29 April 2026 Nath Bio-Genes (India) Limited announced its Q4 and FY26 earnings conference call scheduled for May ...
🔥 Also filed on 19 June 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when NATHBIOGEN files new disclosures
Track NATHBIOGEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track NATHBIOGEN — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research